Abstract
Tumor bone metastasis is one of the main causes of treatment failure in tumor. Since tumor bone metastasis is a complex process, the exact etiopathogenesis of tumor bone metastasis has not been clarified. Recent studies demonstrated that osteoprotegerin/receptor activator of NF-κB ligand/receptor activator of NF-κB (OPG/RANKL/RANK) system plays an important role during the development and progression of tumor bone metastasis. In this review, the research progress of OPG/RANKL/RANK system, including biological functions,the bone microenvironment regulation, the detection method,the diagnosis and treatment of tumor will be summerized. Key words: Neoplasm metastasis; Bone neoplasms; Osteoprotegerin; RANK Ligand; Receptor activator of nuclear factor-kappa B
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
